NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/16/2025
Back to search
Official data from USPTO
BOUDICCA DX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BOUDICCA DX
ST13
US500000099152709Class
35, 42
Filing
99152709
Registration
8066220
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
12/17/2025
Trademark type
Word
Nice classes
35, 42
Filing date
04/24/2025
Registration date
12/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/16/2025
Last transaction
12/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2019-08-00
First use in commerce
2019-08-00
Drawing code
4
Owner type
16
Owner location
Brentwood, TN
Examiner
BECHHOFER,YOCHEVED D
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BOUDICCA DX, LLC
Representatives
Samuel A Raque Patterson Intellectual Property Law, P.C.
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services in the field of precision medicine products; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Business consultation in the field of precision medicine products; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval
Class 42
Technical writing; Product development consulting in the field of precision medicine products; Innovation consulting servicesadvising others in the areas of product development; Consulting services in the field of product design and development; Scientific research consulting in the field of precision medicine products; Scientific research consulting; Consulting services in the field of pharmaceutical research; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of genetic science; Consulting services in the field of pharmacogenetics; Technological planning and consulting services in the field of precision medicine products
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/16/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/28/2025
PUBO
PUBLISHED FOR OPPOSITION
10/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/25/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/25/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/25/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/25/2025
DOCK
ASSIGNED TO EXAMINER
09/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2025
NWAP
NEW APPLICATION ENTERED
04/24/2025
Continuous trademark protection
Get notified about every new filing that threatens BOUDICCA DX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.